New mobile dental health unit provides dental exams and preventive services at no cost.
DANVILLE, Pa. – Although largely preventable, cavities are one of the most common chronic diseases among children in the United States and are twice as likely in children from low-income families.
However, many children have not seen their dentists due to the coronavirus disease 2019. With its new mobile dental services unit, Geisinger has taken dental care on the road to deliver no-cost dental exams and preventive services to children in pre-K through grade 12 throughout its service area.
The 38-foot-long bus is outfitted with two fully equipped dental operatories to provide a full spectrum of preventive and diagnostic services at no cost, such as dental exams, X-rays, cleanings, fluoride treatments and sealants, as well as home care education and nutritional counseling.
“Some of the most common barriers to proper dental health are transportation, access to care and financial barriers,” said Kristen Schintz, DMD, medical director for dental services at Geisinger Health Plan. “We hope to alleviate those barriers by going into underserved areas and developing relationships with schools so that patients can be seen during their school day.”
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More